MedTrace Logo

Emotional Regulation, Impulsivity in Cannabis Its Relation to MRI Brain Structure

NCT03483220 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2022-01-25

No results posted yet for this study

Summary

cannabis addiction is a major health hazard that has its effect on personality and behavior including the impulsivity and emotional regulation. It also has its effect on both the structure and function of different brain regions involved in brain reward system.

the aim of the study is to study the emotional regulation and impulsivity among people with cannabis addiction studying the change in the volume of brain reward system structures' volume in relation to cannabis addiction and the change in the mentioned behavioral traits.

Conditions

Interventions

DIAGNOSTIC_TEST

MRI brain

1\. Emotion Regulation Questionnaire (ERQ): A 10-item scale designed to measure respondents' tendency to regulate their emotions in two ways: (1) Cognitive Reappraisal and (2) Expressive Suppression. Respondents answer each item on a 7-point Likert-type scale . UPPS-P Impulsive Behavior Scale- Short form: The UPPS-P impulsivity scale is a 20-item scale designed to assess five distinct personality traits to impulsive behavior: Negative Urgency, Lack of Perseverance, Lack of Premeditation, Positive Urgency and Sensation Seeking . Magnetic resonance imaging examination: The MR examination of brain was done using 1.5T MR scanner (Achieva, Philips Medical Systems, The Netherlands) with a 16 channel head coil without using any sedation.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Khaled AM Elbeh, professor · Assiut University

  • Yasser M Elsorogy, professor · Assiut University

  • Gilan K Ramadan, Lecturer · Assiut University

  • Gehan S Seif, professor · Assiut University

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-09-30
Completion
2021-12-20

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03483220 on ClinicalTrials.gov